These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7864945)

  • 61. Variation in test results for APC resistance with factor V deficient plasma from different donors.
    Jones MP; Carrington L; Cutting M; Alving B
    Thromb Haemost; 1997 Mar; 77(3):601. PubMed ID: 9066017
    [No Abstract]   [Full Text] [Related]  

  • 62. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
    De Bel AV; Van der Cruyssen GA; Devreese KM
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced anticoagulant response to activated protein C in patients with IDDM.
    Krugluger W; Kopp HP; Schernthaner G; Hopmeier P
    Diabetes; 1995 Sep; 44(9):1033-7. PubMed ID: 7657025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.
    Sedano-Balbás S; Lyons M; Cleary B; Murray M; Gaffney G; Maher M
    J Pregnancy; 2011; 2011():232840. PubMed ID: 21869933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Issues concerning the laboratory investigation of inherited thrombophilia.
    Tripodi A
    Mol Diagn; 2005; 9(4):181-6. PubMed ID: 16392896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genetic thrombophilia in patients with retinal vascular occlusion.
    Greiner K; Peetz D; Winkgen A; Prellwitz W; Pfeiffer N; Hafner G
    Int Ophthalmol; 1999; 23(3):155-60. PubMed ID: 11456253
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnosis and management of inherited and acquired thrombophilias.
    Spencer FA; Becker RC
    J Thromb Thrombolysis; 1999 Apr; 7(2):91-104. PubMed ID: 10364773
    [No Abstract]   [Full Text] [Related]  

  • 69. Activated protein C resistance in patients with central retinal vein occlusion.
    Larsson J; Sellman A; Bauer B
    Br J Ophthalmol; 1997 Oct; 81(10):832-4. PubMed ID: 9486021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 71. A more discriminating test for APC resistance and a possible screening test to include protein C and protein S.
    Denson KW; Haddon ME; Reed SV; Davidson S; Littlewood TJ
    Thromb Res; 1996 Jan; 81(1):151-6. PubMed ID: 8747530
    [No Abstract]   [Full Text] [Related]  

  • 72. False positive activated protein C resistance test due to anti-phospholipid antibodies is corrected by platelet extract.
    Martorell JR; Muñoz-Castillo A; Gil JL
    Thromb Haemost; 1995 Aug; 74(2):796-7. PubMed ID: 8585026
    [No Abstract]   [Full Text] [Related]  

  • 73. Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma.
    Strobl FJ; Hoffman S; Huber S; Williams EC; Voelkerding KV
    Arch Pathol Lab Med; 1998 May; 122(5):430-3. PubMed ID: 9593344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlation between the functional assay for activated protein C resistance and factor V Leiden in the neonate.
    Sifontes MT; Nuss R; Hunger SP; Jacobson LJ; Waters J; Manco-Johnson MJ
    Pediatr Res; 1997 Dec; 42(6):776-8. PubMed ID: 9396556
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modified test for activated protein C resistance.
    Jorquera JI; Montoro JM; Fernández MA; Aznar JA; Aznar J
    Lancet; 1994 Oct; 344(8930):1162-3. PubMed ID: 7864945
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.